Register entryShortage reported
- Registered sites
- 1
- Active NDC listings
- 9
- Labeller names
- 2
- Live patents
- 0
- Shortage listings
- 1
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Finished drug manufacture1Relabelling1Repackaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Lifsa Drugs LLC | 317 George St FL 3, New Brunswick, New Jersey (NJ) 08901, United States (USA) | Finished drug manufacture, Relabelling, Repackaging | 3016774395081205160 |
Alert
Drug shortage listings
1| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Isocarboxazid TabletPsychiatry | Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01) | Current | Limited Availability | 16 Apr 20266 Aug 2026 |
Catalogue
Drug listings by form and route
99 active NDC listings: 9 human prescription drug. By marketing category: ANDA 8, NDA 1.
| Dosage form | NDCs |
|---|---|
| tablet | 6 |
| capsule, liquid filled | 1 |
| solution | 1 |
| tablet, orally disintegrating | 1 |
| Route | NDCs |
|---|---|
| oral | 9 |
| Labeller name on the listing | NDCs |
|---|---|
| lifsa drugs llc | 7 |
| lifsa drugs, llc | 2 |
Catalogue
Marketed products
9| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Chlorzoxazone | Chlorzoxazone | tablet, oral | 72336-225ANDA |
| Diclofenac Potassium | Diclofenac potassium | capsule, liquid filled, oral | 72336-432ANDA |
| Glimepiride 3 mg | Glimepiride | tablet, oral | 72336-641ANDA |
| MARPLAN | isocarboxazid | tablet, oral | 72336-032NDA |
| Metformin Hydrochloride | Metformin Hydrochloride | tablet, oral | 72336-064ANDA |
| Metformin Hydrochloride | Metformin Hydrochloride | tablet, oral | 72336-095ANDA |
| Ondansetron | Ondansetron | tablet, orally disintegrating, oral | 72336-073ANDA |
| Tolmetin Sodium | Tolmetin Sodium | tablet, oral | 72336-118ANDA |
| Valsartan | Valsartan | solution, oral | 72336-910ANDA |
Neighbours
Registered in the same town
2- Spectrum Pharmaceuticals, Inc.NEW BRUNSWICK, NJ
- Amella Pharma, LLCNew Brunswick, NJ
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Lifsa Drugs LLC FDA approved?
- Lifsa Drugs LLC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Lifsa Drugs LLC's drugs manufactured?
- The FDA register lists New Brunswick, NJ. Registered operations: finished drug manufacture, relabelling, repackaging.
- What drugs does Lifsa Drugs LLC make?
- 9 products are listed under Lifsa Drugs LLC in the openFDA NDC Directory, most often as tablet; capsule, liquid filled; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Lifsa Drugs LLC products in shortage?
- 1 presentation is currently listed in the FDA drug shortage database under Lifsa Drugs LLC, covering Isocarboxazid Tablet.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.